Mink Therapeutics target price raised to $50 from $43
INKT•B. Riley raised its target price for Mink Therapeutics to $50 from $43.
Related News
Amplitech Group receives $1.03 million follow-on order for satellite communications customer
AMPG•
Applied Energetics to exhibit counter-drone laser technology at Air Force Innovation Expo
AERG•
Schrödinger to report third-quarter financial results
SDGR•
Parke Bancorp announces third-quarter 2026 earnings
PKBK•
Cencora to acquire American Oncology Network in $2.4 billion deal
COR•